PUBLIC COMPANY

$CYTKCYTOKINETICS INC

$CYTK77.18-0.72%

South San Francisco, CA, USupdated 12h ago

Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.

Website SEC EDGAR Yahoo Finance

community read0 votes

pipeline

marketed

phase 3

catalysts ytd

approvals ytd

recalls ytd

Pipeline(3)

pipeline depth3 products

1Phase 21Marketed1Unknown

Marketed

aficamten

Hypertrophic Cardiomyopathy

Phase 2

ulacamten

Diastolic Heart Failure (HFpEF)

drug

MYQORZO

1 INDICATIONS AND USAGE MYQORZO is indicated for the trea…

Upcoming

no upcoming catalysts on record

Recent(90d)

earnings (1)

CYTOKINETICS INC earnings

CYTOKINETICS INC

→

view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

Apr 21, 26SELLMalik Fady Ibraham· EVP Research & Development3,500 sh @ $65.69−$230K↗
Apr 15, 26SELLCallos Andrew· EVP, Chief Commercial Officer7,449 sh @ $66.02−$492K↗
Apr 15, 26SELLBlum Robert I· President & CEO7,500 sh @ $65.38−$490K↗
Apr 7, 26SELLMalik Fady Ibraham· EVP Research & Development3,500 sh @ $65.21−$228K↗
Apr 7, 26SELLMalik Fady Ibraham· EVP Research & Development1,000 sh @ $64.75−$65K↗
Apr 1, 26SELLBlum Robert I· President & CEO7,500 sh @ $66.63−$500K↗
Mar 31, 26SELLCallos Andrew· EVP, Chief Commercial Officer3,639 sh @ $65.00−$237K↗
Mar 18, 26SELLCallos Andrew· EVP, Chief Commercial Officer1,930 sh @ $62.07−$120K↗
Mar 17, 26SELLBlum Robert I· President & CEO23,928 sh @ $62.15−$1.49M↗
Mar 17, 26SELLBlum Robert I· President & CEO12,673 sh @ $62.15−$788K↗
Mar 17, 26SELLMalik Fady Ibraham· EVP Research & Development7,636 sh @ $62.15−$475K↗
Mar 17, 26SELLCallos Andrew· EVP, Chief Commercial Officer5,626 sh @ $62.15−$350K↗
Mar 17, 26SELLLee Sung· EVP, Chief Financial Officer4,935 sh @ $62.15−$307K↗
Mar 17, 26SELLMalik Fady Ibraham· EVP Research & Development4,397 sh @ $62.15−$273K↗
Mar 17, 26SELLCallos Andrew· EVP, Chief Commercial Officer2,916 sh @ $62.15−$181K↗
Mar 16, 26SELLCallos Andrew· EVP, Chief Commercial Officer1,709 sh @ $61.03−$104K↗
Mar 9, 26SELLBlum Robert I· President & CEO7,931 sh @ $60.72−$482K↗
Mar 9, 26SELLMalik Fady Ibraham· EVP Research & Development2,907 sh @ $60.72−$177K↗
Mar 9, 26SELLCallos Andrew· EVP, Chief Commercial Officer2,582 sh @ $60.72−$157K↗
Mar 5, 26SELLCallos Andrew· EVP, Chief Commercial Officer15,000 sh @ $61.87−$928K↗

🐶 Hiring Signal

8 open roles at CYTOKINETICS INC →

Where CYTOKINETICS INC is staffing up — a leading indicator of pipeline and commercial priorities.

therapeutic areaCardiovascular 8

departmentCommercial 2 Manufacturing / CMC 2 Medical Affairs 2 Quality 1 R&D / Discovery 1

News

no news has mentioned this company yet

Data sources

SEC EDGAR · openFDA

last refreshed 2m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

PUBLIC COMPANY

save

$CYTKCYTOKINETICS INC

$CYTK77.18-0.72%

South San Francisco, CA, USupdated 12h ago

Website SEC EDGAR Yahoo Finance

community read0 votes

pipeline

marketed

phase 3

catalysts ytd

approvals ytd

recalls ytd

Pipeline(3)

pipeline depth3 products

1Phase 21Marketed1Unknown

Marketed

aficamten

Hypertrophic Cardiomyopathy

Phase 2

ulacamten

Diastolic Heart Failure (HFpEF)

drug

MYQORZO

1 INDICATIONS AND USAGE MYQORZO is indicated for the trea…

Upcoming

no upcoming catalysts on record

Recent(90d)

earnings (1)

CYTOKINETICS INC earnings

CYTOKINETICS INC

→

view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

Apr 21, 26SELLMalik Fady Ibraham· EVP Research & Development3,500 sh @ $65.69−$230K↗
Apr 15, 26SELLCallos Andrew· EVP, Chief Commercial Officer7,449 sh @ $66.02−$492K↗
Apr 15, 26SELLBlum Robert I· President & CEO7,500 sh @ $65.38−$490K↗
Apr 7, 26SELLMalik Fady Ibraham· EVP Research & Development3,500 sh @ $65.21−$228K↗
Apr 7, 26SELLMalik Fady Ibraham· EVP Research & Development1,000 sh @ $64.75−$65K↗
Apr 1, 26SELLBlum Robert I· President & CEO7,500 sh @ $66.63−$500K↗
Mar 31, 26SELLCallos Andrew· EVP, Chief Commercial Officer3,639 sh @ $65.00−$237K↗
Mar 18, 26SELLCallos Andrew· EVP, Chief Commercial Officer1,930 sh @ $62.07−$120K↗
Mar 17, 26SELLBlum Robert I· President & CEO23,928 sh @ $62.15−$1.49M↗
Mar 17, 26SELLBlum Robert I· President & CEO12,673 sh @ $62.15−$788K↗
Mar 17, 26SELLMalik Fady Ibraham· EVP Research & Development7,636 sh @ $62.15−$475K↗
Mar 17, 26SELLCallos Andrew· EVP, Chief Commercial Officer5,626 sh @ $62.15−$350K↗
Mar 17, 26SELLLee Sung· EVP, Chief Financial Officer4,935 sh @ $62.15−$307K↗
Mar 17, 26SELLMalik Fady Ibraham· EVP Research & Development4,397 sh @ $62.15−$273K↗
Mar 17, 26SELLCallos Andrew· EVP, Chief Commercial Officer2,916 sh @ $62.15−$181K↗
Mar 16, 26SELLCallos Andrew· EVP, Chief Commercial Officer1,709 sh @ $61.03−$104K↗
Mar 9, 26SELLBlum Robert I· President & CEO7,931 sh @ $60.72−$482K↗
Mar 9, 26SELLMalik Fady Ibraham· EVP Research & Development2,907 sh @ $60.72−$177K↗
Mar 9, 26SELLCallos Andrew· EVP, Chief Commercial Officer2,582 sh @ $60.72−$157K↗
Mar 5, 26SELLCallos Andrew· EVP, Chief Commercial Officer15,000 sh @ $61.87−$928K↗

🐶 Hiring Signal

8 open roles at CYTOKINETICS INC →

Where CYTOKINETICS INC is staffing up — a leading indicator of pipeline and commercial priorities.

therapeutic areaCardiovascular 8

departmentCommercial 2 Manufacturing / CMC 2 Medical Affairs 2 Quality 1 R&D / Discovery 1

News

no news has mentioned this company yet

Data sources

SEC EDGAR · openFDA

last refreshed 2m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

$CYTKCYTOKINETICS INC

Pipeline(3)

Upcoming

Recent(90d)

Insider activity

open-market buys + sells

News

Report a data issue

comments(0)

$CYTKCYTOKINETICS INC

Pipeline(3)

Upcoming

Recent(90d)

Insider activity

open-market buys + sells

News

Report a data issue

comments(0)

$CYTKCYTOKINETICS INC

Pipeline(3)

📅 Upcoming

🕒 Recent(90d)

Insider activity

open-market buys + sells

News

comments(0)

$CYTKCYTOKINETICS INC

Pipeline(3)

📅 Upcoming

🕒 Recent(90d)

Insider activity

open-market buys + sells

News

comments(0)

Upcoming

Recent(90d)

Upcoming

Recent(90d)